Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration

A 41-year-old woman with metastatic glucagonoma and the characteristic disabling rash, necrolytic migratory erythema, was treated with a synthetic somatostatin analog while waiting to undergo curative surgical resection. Plasma glucagon concentration (1,500-3,300 pg/ml, normal less than 200) remaine...

Ausführliche Beschreibung